These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36003515)

  • 1. Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation.
    Humphries DC; Mills R; Boz C; McHugh BJ; Hirani N; Rossi AG; Pedersen A; Schambye HT; Slack RJ; Leffler H; Nilsson UJ; Wang W; Sethi T; Mackinnon AC
    Front Pharmacol; 2022; 13():949264. PubMed ID: 36003515
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective Myeloid Depletion of Galectin-3 Offers Protection Against Acute and Chronic Lung Injury.
    Humphries DC; Mills R; Dobie R; Henderson NC; Sethi T; Mackinnon AC
    Front Pharmacol; 2021; 12():715986. PubMed ID: 34526900
    [No Abstract]   [Full Text] [Related]  

  • 3. Protectin DX Exhibits Protective Effects in Mouse Model of Lipopolysaccharide-Induced Acute Lung Injury.
    Tan W; Chen L; Wang YX; Hu LS; Xiong W; Shang Y; Yao SL
    Chin Med J (Engl); 2018 May; 131(10):1167-1173. PubMed ID: 29553051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
    Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
    Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omentin-1 protects against bleomycin-induced acute lung injury.
    Zhou Y; Hao C; Li C; Huang X; Li X; Tang Y; Huang Y; Tang S; Liu W; Feng D; Xu J; Yue S; Xie H; Luo Z
    Mol Immunol; 2018 Nov; 103():96-105. PubMed ID: 30245266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 ameliorates lipopolysaccharide-induced acute lung injury via AMPK-Nrf2 pathway in mice.
    Huang XT; Liu W; Zhou Y; Sun M; Yang HH; Zhang CY; Tang SY
    Free Radic Biol Med; 2020 Jan; 146():222-233. PubMed ID: 31711983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
    Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
    Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment.
    Jayne JG; Bensman TJ; Schaal JB; Park AYJ; Kimura E; Tran D; Selsted ME; Beringer PM
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):310-319. PubMed ID: 28954201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Alveolar Macrophage Pyroptosis Reduces Lipopolysaccharide-induced Acute Lung Injury in Mice.
    Wu DD; Pan PH; Liu B; Su XL; Zhang LM; Tan HY; Cao Z; Zhou ZR; Li HT; Li HS; Huang L; Li YY
    Chin Med J (Engl); 2015 Oct; 128(19):2638-45. PubMed ID: 26415803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS
    Zhang C; Wang X; Wang C; He C; Ma Q; Li J; Wang W; Xu YT; Wang T
    Front Pharmacol; 2021; 12():790072. PubMed ID: 35002723
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrocytes Ameliorate Acute Lung Injury by Decreasing Inflammatory Cytokine and Chemokine Levels and Reducing Neutrophil Accumulation in the Lung.
    Tai W; Xu Y; Ding J; Wu H; Du M; Qu X; Gao L; Li J; Dong Z
    Cell Physiol Biochem; 2017; 44(4):1526-1536. PubMed ID: 29197869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
    Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
    J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition Of JNK Phosphorylation By Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury.
    Xiao Z; Xu F; Zhu X; Bai B; Guo L; Liang G; Shan X; Zhang Y; Zhao Y; Zhang B
    Drug Des Devel Ther; 2019; 13():4161-4171. PubMed ID: 31849448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing Angiopoietin-Like Protein 4 (ANGPTL4) Protects Against Lipopolysaccharide-Induced Acute Lung Injury Via Regulating SIRT1 /NF-kB Pathway.
    Guo L; Li S; Zhao Y; Qian P; Ji F; Qian L; Wu X; Qian G
    J Cell Physiol; 2015 Oct; 230(10):2390-402. PubMed ID: 25727991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice.
    Nguyen N; Xu S; Lam TYW; Liao W; Wong WSF; Ge R
    Mol Med; 2022 Jun; 28(1):72. PubMed ID: 35752760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-9 attenuates acute lung injury by expanding CD14- plasmacytoid dendritic cell-like macrophages.
    Kojima K; Arikawa T; Saita N; Goto E; Tsumura S; Tanaka R; Masunaga A; Niki T; Oomizu S; Hirashima M; Kohrogi H
    Am J Respir Crit Care Med; 2011 Aug; 184(3):328-39. PubMed ID: 21562126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice.
    Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M
    Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated IL-33 promotes expression of MMP2 and MMP9 via activating STAT3 in alveolar macrophages during LPS-induced acute lung injury.
    Liang Y; Yang N; Pan G; Jin B; Wang S; Ji W
    Cell Mol Biol Lett; 2018; 23():52. PubMed ID: 30410547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.
    Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN
    Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with interleukin 35-engineered mesenchymal stem cells protected against lipopolysaccharide-induced acute lung injury via pulmonary inflammation suppression.
    Zhang X; Zhang Z; Ju M; Li J; Jing Y; Zhao Y; Gu C; Dong M; Li G; Liu Y
    Inflammopharmacology; 2020 Oct; 28(5):1269-1281. PubMed ID: 32170527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.